...
首页> 外文期刊>Eurosurveillance >Increased detection in Australia and Singapore of a novel influenza A(H1N1)2009 variant with reduced oseltamivir and zanamivir sensitivity due to a S247N neuraminidase mutation
【24h】

Increased detection in Australia and Singapore of a novel influenza A(H1N1)2009 variant with reduced oseltamivir and zanamivir sensitivity due to a S247N neuraminidase mutation

机译:由于S247N神经氨酸酶突变,增加了在澳大利亚和新加坡检测到的新型A型流感(H1N1)2009变异株的奥司他韦和扎那米韦敏感性的降低

获取原文

摘要

A novel influenza A(H1N1)2009 variant with mildly reduced oseltamivir and zanamivir sensitivity has been detected in more than 10% of community specimens in Singapore and more than 30% of samples from northern Australia during the early months of 2011. The variant, which has also been detected in other regions of the Asia-Pacific, contains a S247N neuraminidase mutation. When combined with the H275Y mutation, as detected in an oseltamivir-treated patient, the dual S247N+H275Y mutant had extremely high oseltamivir resistance.
机译:在2011年前几个月,在新加坡超过10%的社区标本和澳大利亚北部超过30%的标本中检测到了一种新的带有轻微降低的oseltamivir和zanamivir敏感性的A(H1N1)2009流感变种。在亚太其他地区也已检测到这种病毒,该病毒含有S247N神经氨酸酶突变。如在经奥司他韦治疗的患者中检测到的与H275Y突变结合使用时,双重S247N + H275Y突变体具有极高的奥司他韦耐药性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号